Skip to main content

Table 3 The league table for results based on Cox-regression estimates various agents according to their relative effects with hazard ratio (95% confidence interval)

From: Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis

Atorvastatin (0.626)

0.90 (0.82–0.99)

      

0.90 (0.82–0.99)

Control (0.159)

1.12 (1.08–1.17)

1.18 (0.96–1.45)

0.99 (0.90–1.08)

1.05 (0.99–1.10)

1.02 (0.90–1.15)

1.38 (1.17–1.61)

1.01 (0.91–1.12)

1.12 (1.08–1.17)

EPA (0.690)

     

1.07 (0.85–1.34)

1.18 (0.96–1.45)

1.05 (0.85–1.30)

Ezetimibe (0.739)

    

0.89 (0.78–1.01)

0.99 (0.90–1.08)

0.88 (0.80–0.97)

0.83 (0.67–1.04)

Omega-3 fatty acid (0.138)

   

0.94 (0.84–1.05)

1.05 (0.99–1.10)

0.93 (0.87–0.99)

0.88 (0.72–1.09)

1.06 (0.96–1.17)

Fenofibrate (0.395)

  

0.92 (0.79–1.07)

1.02 (0.90–1.15)

0.91 (0.80–1.03)

0.86 (0.68–1.09)

1.03 (0.89–1.20)

0.97 (0.85–1.11)

Niacin (0.275)

 

1.24 (1.03–1.50)

1.38 (1.17–1.61)

1.22 (1.04–1.44)

1.16 (0.90–1.51)

1.39 (1.16–1.67)

1.32 (1.11–1.56)

1.35 (1.11–1.65)

Simvastatin (0.979)

  1. EPA eicosapentaenoic acid
  2. Italic font means statistical difference. Traditional pairwise at upper right side, network pairwise at lower left side
  3. #The P-score is performed in brackets